Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Deviation and Corrective Action

Posted on By

Standard Operating Procedure for Deviation and Corrective Action

Purpose

The purpose of this SOP is to establish procedures for the identification, documentation, investigation, and resolution of deviations from established processes or procedures within the pharmaceutical manufacturing facility. Additionally, it outlines the steps for implementing corrective actions to prevent recurrence.

Scope

This SOP applies to all personnel involved in the manufacturing, quality control, and quality assurance of pharmaceutical products, including operators, technicians, and quality assurance personnel.

Responsibilities

  • All Personnel: Responsible for immediately reporting any observed or potential deviations from standard processes or procedures.
  • Operators and Technicians: Responsible for documenting and reporting deviations during their respective activities.
  • Quality Assurance Personnel: Responsible for overseeing the deviation investigation and ensuring the implementation of corrective actions.
See also  SOP for Data Retention and Archiving

Procedure

  1. Deviation Identification: Immediately report any observed or potential deviations from standard processes or procedures to the appropriate supervisor or quality personnel.
  2. Deviation Documentation: Document all relevant details of the observed deviation, including the date, time, location, personnel involved, and a brief description of the deviation.
  3. Deviation Classification: Classify deviations based on their severity and potential impact on product quality, patient safety, and regulatory compliance.
  4. Deviation Investigation: Initiate a thorough investigation to identify the root cause of the deviation. Involve relevant personnel, including operators, technicians, and quality assurance personnel.
  5. Investigation Report: Prepare a detailed deviation investigation report, including findings, root cause analysis, and proposed corrective actions.
  6. Corrective Action Plan: Develop a corrective action plan to address the root cause and prevent the recurrence of the deviation. Include specific actions, responsibilities, and timelines.
  7. Implementation of Corrective Actions: Execute the corrective action plan in a timely manner. Ensure that all personnel involved are aware of and trained on the corrective actions.
  8. Effectiveness Check: Conduct an effectiveness check to verify that the corrective actions have been implemented successfully and are preventing recurrence.
  9. Documentation of Corrective Actions: Document all corrective actions taken, including updates to procedures, training records, and any changes made to prevent similar deviations in the future.
  10. Approval: Obtain necessary approvals for the deviation investigation report and the effectiveness check before closing the deviation.
  11. Communication: Communicate the resolution of the deviation to relevant personnel and stakeholders as necessary.
  12. Review and Trend Analysis: Periodically review deviation records and perform trend analysis to identify recurring issues and implement proactive measures.
  13. Archiving: Archive deviation records in accordance with established retention policies.
See also  SOP for Data Integrity in Computerized Systems Validation

Abbreviations

No abbreviations are used in this SOP.

Documents

  • Deviation Logbook
  • Deviation Investigation Report
  • Corrective Action Plan
  • Effectiveness Check Records

Reference

ICH Q9 – Quality Risk Management

SOP Version

Version 1.0

Data Integrity Tags:Data accuracy, Data assurance, Data audit, Data confidentiality, Data consistency, Data encryption, Data governance, Data protection, Data quality, Data reliability, Data security, Data transparency, Data validation, Data verification, Database integrity, Information assurance, Information integrity, Trustworthy data

Post navigation

Previous Post: SOP for Data Integrity Training
Next Post: SOP for Audit Trail Review

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version